1[1]Day CP.Natural history of NAFLID:remarkably benign in the absence of cirrhosis[J].Gastroenterology,2005,129(1):375-378.
2[3]Raunch U,Osende J1,Chesebm JH,et al.Statins and cardiovascular diseases:the multiple effects of lipid-lowering therapy by statins[J].Atherosclerosis,2000,153(1):181-189.
3[4]Santos VN,Lanzoni VP,Szejnfeld J,et al.A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxyehdic acid[J].Braz J Med Bid Res,2003,36(6):723-729.
4[5]Cohen DE,Anania FA,Chalasani N.An assessment of stalin safety by hepatologists[J].Am J Cardiol,2006,97(8A):77C-81C.
同被引文献7
1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量：1516
